Drug
Inhaled loxapine 10 mg
Inhaled loxapine 10 mg is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Phase Distribution
Ph phase_3
2
33%
Ph phase_2
1
17%
Ph phase_4
1
17%
Ph phase_1
2
33%
Phase Distribution
2
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 41 (16.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
Staccato Loxapine Single Dose PK
NCT00444028
completedphase_2
Staccato Loxapine in Agitation (Proof of Concept)
NCT00369577
completedphase_4
ADASUVE-Lorazepam Drug-Drug Interaction
NCT01877642
completedphase_3
Staccato Loxapine in Agitated Patients With Bipolar Disorder
NCT00721955
completedphase_3
Staccato Loxapine in Agitated Patients With Schizophrenia
NCT00628589
Clinical Trials (6)
Showing 6 of 6 trials
NCT00444028Phase 1
Staccato Loxapine Single Dose PK
NCT00369577Phase 2
Staccato Loxapine in Agitation (Proof of Concept)
NCT01877642Phase 4
ADASUVE-Lorazepam Drug-Drug Interaction
NCT00721955Phase 3
Staccato Loxapine in Agitated Patients With Bipolar Disorder
NCT00628589Phase 3
Staccato Loxapine in Agitated Patients With Schizophrenia
NCT00873769Phase 1
Staccato Loxapine PK in Smokers and Nonsmokers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6